- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 11-08-2026: Press Release
11-08-2026 | 01:30 pm
11-08-2026 | 01:30 pm
Zydus Lifesciences' Q1 revenue grew 22% to ₹8,017 Cr, but net profit fell 36% to ₹939.8 Cr. Strong growth in Consumer Wellness (+67%), India (+20%), and International Markets (+34%). Key strategic moves include the US launch of biosimilar NUFYMCO™ and Saroglitazar's US NDA receiving priority review.
No comments yet. Be the first to comment!